The purpose of this study is to evaluate the association between anxiety and depressive symptoms and obesity among adolescent females using objective measures of adiposity and evaluate for moderating effects of race and age. This is a cross-sectional analysis of 198 females aged 11, 13, 15, and 17 years (mean = 14.6, standard deviation = 2.2). Adiposity measures include BMI, BMI Z score, percentage body fat from dual energy X-ray absorptiometry (DXA), and fat distribution (fat mass upper vs lower body regions from DXA). Symptoms of anxiety are measured with the State-Trait Anxiety Inventory and depressive symptoms with the Children's Depression Inventory. Trait anxiety and depressive symptoms are positively associated with BMI and percentage body fat. No interaction of anxiety/ depressive symptoms with race or age on measures of adiposity was detected. Symptoms of anxiety and depression are associated with percentage body fat among adolescent females, linking psychological distress with a physiological measure of adiposity.
Introduction
There is a high prevalence of obesity and mood disorders among adolescents, with both disorders imparting substantial costs to society and the individual. 1, 2 Additionally, obesity and anxiety/depressive disorders may co-occur. Previous studies have evaluated the association between depressive symptoms and obesity in children, adolescents, and adults, and the majority of studies have found a positive association between depressive symptoms and obesity, [3] [4] [5] [6] [7] [8] [9] whereas fewer studies have found no clear association. [10] [11] [12] [13] Experts have called for more rigorous assessments of adiposity in studies involving children and adolescents, emphasizing that BMI and BMI Z score (BMI-Z) are surrogate measures for adiposity. 14 Furthermore, experts argue that excess adipose tissue, not lean mass, poses an increased risk of adverse health outcomes. Additionally, visceral (central) versus peripheral adiposity is associated with increased risk of cardiovascular disease. [15] [16] [17] However, little is known about visceral adiposity and its association with psychological disorders.
Few studies have evaluated the association of anxiety with adiposity during adolescence. 3, 9 Anxiety is frequently comorbid with other mood disorders. In particular, anxiety often precedes the development of depression in adolescent females. 18 It is crucial to gain a better understanding of the relationship between anxiety and depressive symptoms and obesity in adolescence as this is a critical time for both physical and psychosocial development.
The literature evaluating the impact of race and/or age on the associations between anxiety/depressive symptoms and obesity in children and adolescents is sparse. It has been suggested that whites are more likely than blacks to experience psychological disturbance related to weight. 9, 19, 20 However, the adult literature is conflicting. A recent study of adult men and women demonstrated that young obese women of all ethnic groups and Hispanic men are at increased risk of depressed mood compared with their nonobese and racial/ethnic group counterparts. 21 Another longitudinal study in adults suggested that the influence of BMI on depressive symptoms was greater among blacks than whites. 22 The adult literature may not completely transfer to adolescence because adolescents place a significantly greater emphasis on physical appearance. Regarding age, Richardson and colleagues 7 found an increased risk for obesity in adulthood among women with depressive symptoms during late adolescence compared with women with depressive symptoms during early adolescence. Evaluation of moderators of this association has significant clinical implications because it may guide clinicians regarding screening efforts.
The primary aim of this study was to evaluate the association between anxiety and depressive symptoms and obesity in adolescent females using BMI, BMI-Z, percentage body fat from dual energy X-ray absorptiometry (DXA), and fat distribution (fat mass in the upper vs the lower body regions from DXA). The latter is similar to a waist-to-hip ratio and has been used as a measure of central adiposity. 23 As secondary aims, we explored whether these associations differed by race and age. We hypothesized that symptoms of anxiety and depression would be positively associated with all measures of adiposity. Based on previous literature, we anticipated a moderating effect of both race and age.
Methods

Study Population
This was a cross-sectional analysis of data from a larger ongoing study evaluating the relationship of psychological symptoms and smoking on reproductive and bone health of adolescents. 24 Healthy females (n = 198) in age cohorts of 11, 13, 15, and 17 years were recruited from an outpatient teen clinic and the surrounding community of a large Midwestern city (Table 1) .
A screening questionnaire was administered to determine initial eligibility. Exclusion criteria included the following: (1) pregnancy or breast feeding within 6 months, (2) primary or secondary amenorrhea, (3) BMI ≤ 1st percentile or weight >300 pounds (limitation of DXA table), (4) medication or medical disorder influencing bone health, and (5) severe psychological disabilities impairing comprehension or compliance. All applicable institutional and governmental regulations concerning the ethical use of human volunteers were followed during this research.
The study was approved by an institutional review board. Parents provided informed consent, and adolescents provided assent. A certificate of confidentiality was obtained to enhance protection of the adolescent's confidentiality. All study visits were conducted in the General Clinical Research Center at a large children's hospital. Parents and adolescents completed their portions of the study separately.
Measures
Psychological. Symptoms of anxiety were measured using the Spielberger State-Trait Anxiety Inventory for Children (STAIC) for females 11 years old 25 and the State Trait Anxiety Inventory (STAI) for those 12 years and older. 26 This self-report questionnaire consists of 20 items measuring state and 20 items measuring trait anxiety. Trait anxiety is thought to reflect how girls generally feel, whereas state anxiety is more reflective of the participant's level of anxiety at the moment of assessment. Trait anxiety was used in the analyses as it was felt to be more relevant to measures of adiposity. Reliability was high in this sample (a = 0.86-0.91). T scores were used in the analyses. By definition, T scores have a mean of 50, standard deviation (SD) of 10, and adjust for age and gender based on a reference sample of healthy children and adolescents. They are commonly used when assessing psychological constructs because they facilitate comparison and clinical interpretation. Symptoms of depression were assessed with the Children's Depression Inventory (CDI), a 27-item self-report measure. 27 The CDI, designed for school-aged children and adolescents, has been rigorously studied in normal and clinical populations with acceptable test-retest and concurrent validity. 27 Reliability was high in this sample (a = 0.90).
Adiposity. Height was obtained by a wall-mounted stadiometer (Holtan Ltd, UK) and weight by a digital scale (Scaletronix, Carol Stream, IL) without shoes and with minimal clothing. Measures were obtained 3 times, and the mean was used. BMI was calculated as weight (kg) divided by height (meters squared). BMI-Z was calculated based on the Centers for Disease Control and Prevention age-and sex-specific standards (www.cdc. gov). DXA Hologic QDR4500A (Hologic, Inc, Bedford, MA) was used to measure body composition. Scans were analyzed using software version 12.4. Percentage body fat was derived from the total body fat (kg) divided by the total body mass (kg). Body composition data from DXA were used to calculate fat distribution as has been described by Walton and colleagues. 23 This method defines 4 regions of interest defined by anatomic landmarks: android subscapular, android waist, gynoid hip, and gynoid thigh. It is defined as the ratio of the fat mass in the 2 upper (android) body regions divided by the 2 lower (gynoid) body regions. 23 Fat distribution is analogous to a waist-to-hip ratio and provides an objective assessment of the pattern of fat deposition. Higher values correspond to a greater degree of central adiposity.
Covariates. The Hollingshead Four Factor Index of Social Status based on parent's education and occupation was used to determine socioeconomic status (SES), in which a higher score corresponds to higher SES. 28 Pubertal stage was determined by breast inspection and palpation and evaluation of pubic hair distribution using criteria described by Marshall and Tanner. 29 Examinations were performed by a trained clinician. Interrater agreement was 100% in a nonrandom sample (n = 23). We used Tanner stage (breast) in the analyses because breast development is typically the first sign of puberty in girls. 29 Physical activity was assessed using the Physical Activity Questionnaire for Older Children. 30 Participants recalled the amount of moderate to vigorous activity over the preceding 7 days. An average was used to create a score ranging from 1 (low activity) to 5 (high activity). Reliability was high in this sample (a = 0.88).
Statistical Analysis
Distributions were assessed for all primary variables and covariates. Adiposity measures were all normally distributed, except for BMI, which was slightly skewed. Logarithm transformation of BMI resulted in normally distributed data, but reanalysis with this transformation did not change the results. Considering the difficulty in interpreting transformed data and the universal understanding of BMI, we have used BMI (untransformed) in the analyses. Anxiety and depressive symptoms were analyzed as separate constructs to evaluate the independent effects on measures of adiposity.
Multiple regression was used to determine the overall effects of trait anxiety and depressive symptoms on obesity after accounting for covariates. Potential covariates were selected based on previous literature and included age, race, SES, Tanner stage (breast), and physical activity. 3, [5] [6] [7] [8] [9] 20 Only significant covariates and confounding variables were retained in the final model. Age and race were included in all models because of biological plausibility. All measures of obesity (BMI, BMI-Z, percentage body fat, fat distribution) in the current study were highly correlated (r = 0.69-0.86), and thus, repeated regression on each measure could have increased type I error. To minimize this error, we conducted multivariate analysis of variance (MANOVA) by including all obesity measures into 1 model.
For our secondary aims, we evaluated the interaction effects of race and age with anxiety/depressive symptoms on obesity measures. Race was classified as either white (n = 123) or nonwhite (n = 75). The nonwhite group consisted of 64 black and 11 biracial or other. Age was dichotomized into girls less than 15 years of age (n = 97, early adolescence) and those 15 and older (n = 101, late adolescence). The significance of the R 2 change for the interaction term was assessed.
Results
Primary Aim: Trait Anxiety and Obesity
Descriptive statistics of key variables and demographic characteristics of the participants are shown in Table 1 . Trait anxiety was positively associated with percentage body fat (P = .02) and BMI (P = .002). Neither BMI-Z nor fat distribution was significantly associated with trait anxiety ( Table 2) .
After controlling for age, race, and Tanner stage (breast), trait anxiety was significantly associated with BMI (P = .05) in a positive direction. Additionally, controlling for age and race, trait anxiety was significantly associated with percentage body fat (P = .05) in a positive direction. An increase of 1 SD in the T score for trait anxiety was associated with a 0.78 unit increase in BMI and a 1.03 unit increase in percentage body fat. There were no significant associations between BMI-Z or fat distribution and trait anxiety ( Table 3) . Physical activity was not significant in any of the models and was dropped from all models.
Primary Aim: Depressive Symptoms and Obesity
Simple regression revealed significant positive associations between depressive symptoms and BMI (P = .002), percentage body fat (P = .004), and fat distribution (P = .03). Symptoms of depression were not significantly associated with BMI-Z (P = .10). Controlling for age, race, and Tanner stage (breast), depressive symptoms were significantly associated with BMI (P = .03) and percentage body fat (P = .01) in a positive direction. An increase of 1 SD in the T score for depressive symptoms was associated with a 0.84 unit increase in BMI and a 1.28 increase in percentage body fat. After controlling for age, race, Tanner stage (breast), and SES, the association between depressive symptoms and fat distribution became nonsignificant.
There was no association between depressive symptoms and BMI-Z (P = .14).
Finally, results from MANOVA revealed a trend for an association between depressive symptoms and adiposity (BMI, BMI-Z, percentage body fat, and fat distribution) after adjusting for age, race, Tanner stage (breast), and SES (Wilks's l F = 2.10; P = .08). Multivariate analyses of the effect of trait anxiety on adiposity was not significant (Wilks's l = 1.00; P = .40).
Secondary Aims: Effect of Race and Age
There were no significant interaction effects of race and anxiety/depressive symptoms with any measure of adiposity. Likewise, age was not a significant moderator of the association between anxiety/depressive symptoms and adiposity.
Discussion
This is the first study to evaluate the association between anxiety and depressive symptoms and obesity among adolescent females using adiposity measures from DXA as well as more standard measures such as BMI calculated from measured height and weight. As hypothesized, trait anxiety and depressive symptoms were positively associated with BMI and percentage body fat. Higher anxiety and depressive symptoms were associated with an increased BMI and a higher percentage of body mass from fat. This association remained significant after controlling for covariates. Although in unadjusted models, depressive symptoms were associated with fat distribution, after controlling for covariates, the association was no longer significant. In contrast to some previous studies, 3, 5 we did not observe an association between anxiety and depressive symptoms and BMI-Z. Furthermore, there was no evidence of an interaction effect between anxiety/depressive symptoms and race on obesity nor between anxiety/depressive symptoms and age on obesity.
The association of anxiety and depressive symptoms and percentage body fat is noteworthy, linking psychological distress with a more objective and physiological measure of adiposity. The clinical implications of our findings are important because we have shown that as early as adolescence, increased symptoms of anxiety and depression are associated with a higher percentage of body mass from fat and higher BMI. For example, for an average height (160 cm, 5'3") adolescent female with a BMI of 20, an increase of 1 SD in her depressive symptoms T score would be associated with 4.7 pounds greater weight, representing 4% of her body weight. In turn, increases in adiposity may continue on an interval basis as the adolescent reaches adulthood and beyond, compounding the effect of anxiety and depressive symptoms on adiposity.
Explanations for the association between anxiety/ depressive symptoms and percentage body fat are unclear at the present time; however, several hypotheses exist. It is known that various substances are regulated by the body in response to the degree of adiposity. For example, leptin secretion is higher with a greater percentage of body fat. 31, 32 In addition to leptin, there are other behavioral and neuroendocrine factors that may mediate this association, including sedentary lifestyle and physical activity, caloric intake, the hypothalamic-pituitaryadrenal axis, and insulin. Furthermore, a recent study among a large cohort of Swedish children (N = 7443) has demonstrated that psychological stress in early childhood may be a contributing factor to the development of obesity at an age as young as 5. 33 Future research is needed to identify mediators between adiposity and anxiety/depression and to better understand the association between psychological stress, mood disorders, and obesity.
The association between symptoms of trait anxiety and percentage body fat has not been previously described. Two earlier studies have found an association between anxiety and BMI-Z. 3, 9 Anderson et al 3 reported higher BMI-Z among females with anxiety disorders compared with females of the same age and SES who did not have anxiety disorders. In this study, the authors included a wide range of anxiety disorders in the analyses, including social phobia, overanxious disorder, separation anxiety, and obsessive-compulsive disorder. Young-Hyman et al 9 evaluated the association between trait anxiety and BMI-Z in a similar manner to the current study, noting a significant positive association with BMI-Z, but did not control for covariates.
We identified an association between anxiety/ depressive symptoms and percentage body fat but not with BMI-Z. Previous studies of adolescents have noted an association between depressive symptoms and BMI/ BMI-Z. [3] [4] [5] [6] [7] [8] [9] Our study found an association between depressive symptoms and BMI but not between depressive symptoms and BMI-Z. Three published studies have found no association between depressive symptoms and BMI-Z. [10] [11] [12] Differences between our study and previous findings could be explained by several factors. First, earlier studies used self-reported height and weight 3, 5, 8 or used a combination of measured and self-reported height and weight. [4] [5] [6] Only 1 study used solely measured height and weight. 7 A strength of our study is that height and weight were measured in a systematic fashion by trained research staff.
A second difference from the previous literature is that other studies evaluated the association between depression and obesity using adolescents diagnosed with major depressive disorder 3,5-7 not depressive symptoms. Our study was designed to enroll a more representative group of girls in the population with variability in depressive symptoms. The presence of an association in adolescents with subclinical symptoms of anxiety and depression is significant.
Finally, our sample was relatively obese, with 39.9% being overweight or obese and with a mean BMI-Z of 0.7. There were 38 girls (19.2%) with a BMI-Z greater than the 95th percentile for age and gender. At extreme degrees of obesity, BMI-Z may not adequately describe and quantify the degree of excess adiposity. 34 The advantage of using percentage body fat as a measure of adiposity is that it allows for a broader range in adiposity, particularly at the extremes. The ability of percentage body fat to better characterize the degree of adiposity in the severely obese girls may have provided more power to detect an association with anxiety and depressive symptoms.
The cross-sectional design of our study presents a limitation in that causality cannot be determined. Second, we had a smaller number of nonwhite (n = 75) versus white girls (n = 123). Therefore, this study may not have been powered to detect moderation effects by race. Our sample consisted only of female participants, so we cannot conclude anything about adolescent males in terms of the associations between anxiety/depressive symptoms and adiposity. However, previous literature has demonstrated that this association has a significantly greater impact on women compared with men. Although we demonstrated a trend for significance in the association between depressive symptoms and all measures of adiposity using multivariate analyses (MANOVA), this robust statistical technique still substantiates our findings in terms of depressive symptoms to some extent. In terms of anxiety, the results of MANOVA did not substantiate an overall association between trait anxiety and adiposity.
Conclusions
In summary, trait anxiety and depressive symptoms are associated with a higher BMI and percentage body fat among adolescent females. The fact that we found a significant association between BMI and percentage body fat and anxiety/depressive symptoms and not between BMI-Z and anxiety/depressive symptoms suggests that either there is some physiological impact of body fat that relates to anxiety/depression and/or there are differences in these 2 measures of adiposity. Alternatively, it may be reflective of statistical limitations with use of BMI-Z in obese samples. Studies evaluating associations between obesity and other disorders should consider using a direct means of assessing adiposity, especially among children and adolescents, where the use of BMI/BMI-Z may be less accurate. Future studies evaluating potential neuroendocrine and behavioral mediators of this association may help determine a common pathway between these 2 disorders and may lead to a means of prevention and treatment.
